VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,000 | +25.0% | 7,149 | +81.9% | 0.00% | – |
Q2 2023 | $12,000 | +100.0% | 3,931 | +369.1% | 0.00% | – |
Q4 2022 | $6,000 | 0.0% | 838 | -46.7% | 0.00% | – |
Q3 2022 | $6,000 | -14.3% | 1,572 | +34.8% | 0.00% | – |
Q1 2022 | $7,000 | -84.1% | 1,166 | -69.5% | 0.00% | – |
Q4 2021 | $44,000 | +46.7% | 3,817 | +100.7% | 0.00% | – |
Q3 2021 | $30,000 | +100.0% | 1,902 | +143.5% | 0.00% | – |
Q2 2021 | $15,000 | -67.4% | 781 | -27.6% | 0.00% | – |
Q1 2021 | $46,000 | – | 1,078 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $38,425,000 | 8.39% |
OUP Management Co., LLC | 374,714 | $2,263,000 | 1.72% |
RA Capital Management | 11,120,973 | $67,171,000 | 1.47% |
Paradigm Biocapital Advisors LP | 894,404 | $5,402,000 | 1.43% |
JOHNSON & JOHNSON | 1,074,658 | $6,491,000 | 1.23% |
Sarissa Capital Management LP | 707,010 | $4,270,000 | 0.40% |
Artal Group S.A. | 550,000 | $3,322,000 | 0.14% |
Woodline Partners LP | 1,111,123 | $6,711,000 | 0.11% |
Orbimed Advisors | 833,333 | $5,033,000 | 0.08% |
Laurion Capital Management LP | 857,308 | $5,178,000 | 0.06% |